How to buy Memphasys shares
Own Memphasys shares in just a few minutes.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Memphasys Limited is a biotechnology business based in Australia. Memphasys shares (MEM) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Memphasys has a market cap (total outstanding shares value) of $54.7 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Memphasys
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Memphasys . Find the share by name or ticker symbol: MEM. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Memphasys reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Memphasys . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Memphasys share priceUse our graph to track the performance of MEM stocks over time.
Memphasys shares at a glance
|52-week range||$0.05 - $0.16|
|50-day moving average||$0.0614|
|200-day moving average||$0.0879|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.003|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Memphasys stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Memphasys price performance over time
|1 week (2021-06-17)||-16.67%|
|1 month (2021-05-24)||15.38%|
|3 months (2021-03-24)||-21.05%|
|6 months (2020-12-24)||-40.00%|
|1 year (2020-06-24)||11.11%|
|2 years (2019-06-24)||150.00%|
|3 years (2018-06-22)||-72.97%|
|5 years (2016-06-24)||-93.22%|
|Gross profit TTM||$0|
|Return on assets TTM||-6.89%|
|Return on equity TTM||-11.55%|
|Market capitalisation||$54.7 million|
TTM: trailing 12 months
Memphasys share dividends
We're not expecting Memphasys to pay a dividend over the next 12 months.
Have Memphasys 's shares ever split?
Memphasys 's shares were split on a 1:15 basis on 15 August 2018. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Memphasys shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Memphasys shares which in turn could have impacted Memphasys 's share price.
Memphasys share price volatility
Over the last 12 months, Memphasys 's shares have ranged in value from as little as $0.05 up to $0.16. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Memphasys 's is -0.3261. This would suggest that Memphasys 's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Memphasys has bucked the trend.
Memphasys Limited, a bio-separations company, develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix that uses high quality sperm cells from semen samples for human assisted reproductive technologies for treating male factor infertility; hydrogels; and other polymer membranes to separate cells from fluids. The company was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. Memphasys Limited was incorporated in 2006 and is headquartered in Homebush, Australia.
Frequently asked questions
More guides on Finder
Barefoot Investor: How to watch Scott Pape’s Money Movement docu-series online
This fresh docu-series features the one and only Barefoot Investor.
Prime Day’s best health and fitness deals: Garmin, FitBit, PranaOn
Stocking up on your favourite supplements or adding to your home gym, Amazon has got you covered with these red-hot offers.
Amazon Prime Day’s best camera deals: Nikon, Panasonic and more
DSLR, digital, polaroids, lenses and accessories - these are the best camera deals Amazon has to offer this Prime Day.
Biggest Amazon Prime Day discounts: 75% off games + heaps more
Top offers so far include 75% off games, 68% off tech and 38% off alcohol.
Jetstar sale offers new route to “Australia’s most beautiful coastlines”
You have to be quick, these fares are gone with the strike of midnight.
Kobo Elipsa review: An ereader and enote 2-in-1
The Kobo Elipsa makes a valiant attempt to bridge the gap between eReader and eNote. It doesn’t manage to excel at being one or the other as its big for an eReader, and slow for an eNote.
Amazon Prime Day: Best board game offers on Hasbro, MONOPOLY, Jenga
From children to teens and adults, Amazon has got you covered with these awesome board game deals.
Amazon Prime Day: Red-hot fashion deals on Bonds, Champion and more
Fashionistas can score sweet savings on Skechers shoes, Bonds everyday essentials and winter warmers from Champion.
Why has the Zip Co share price run out of steam?
Shares in BNPL provider Zip Co have jumped over 16% in the last month.
3 Virgin Australia sales to get you 50% off flights + 50% bonus points
Earn extra points for every $1 spent when you book these domestic flights before the end of the financial year.
Ask an Expert